Jagsonpal Pharmaceuticals Limited (JPL) has acquired the ‘wellness portfolio’ division of Group Pharmaceuticals Limited on a slump sale basis.

ThinkLaw advised and assisted JPL in conducting a legal due diligence on the target business, and on the drafting and negotiation of the business transfer agreement and other transaction documents. The Firm provided end-to-end legal counsel to JPL and also assisted in the closing actions pertaining to the transaction.

The transaction was led by Ankita Kashyap (Partner), with strategic inputs from Tushar Ajinkya (Founder and Managing Partner), and was supported by Saahil Bijliwala (Associate Partner), Parth Mehta (Senior Associate), Kaushik Krishnan (Senior Associate), Associates Darshit Vora and Simran Lakra.

The acquisition will give Jagsonpal an established portfolio of wellness products and an existing market presence. The company intends to combine this portfolio with its current commercial platform and capabilities.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.